Kelly E. Graff
Impact in
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- SARS-CoV-2 detection and testing
-
- COVID-19 Impact on Reproduction
Papers in
-
- COVID-19 Clinical Research Studies 3
- SARS-CoV-2 and COVID-19 Research 1
-
- Bacterial Identification and Susceptibility Testing 3
- Co-authors
- Lisa Abuogi (3 shared papers)Christiana Smith (3 shared papers)Lori J. Silveira (3 shared papers)Elizabeth J. McFarland (1 shared paper)Samuel R. Dominguez (1 shared paper)Lauren M. Carpenter (1 shared paper)Sarah A. Jung (1 shared paper)Samuel R. Dominguez (4 shared papers)
- Journals
- The Pediatric Infectious Disease Journal (3 papers)Journal of the Pediatric Infectious Diseases Society (2 papers)Journal of Clinical Microbiology (1 paper)Microbiology Spectrum (1 paper)BMC Infectious Diseases (1 paper)
- Partner nations
- United StatesGuatemala
In The Last Decade
Kelly E. Graff
9 papers receiving 307 citations
Peers
Comparison fields: 5 of 46
- Infectious Diseases 143
- Obstetrics and Gynecology 31
- Clinical Biochemistry 22
- Neurology 32
- Applied Microbiology and Biotechnology 4
Countries citing papers authored by Kelly E. Graff
This map shows the geographic impact of Kelly E. Graff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly E. Graff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly E. Graff more than expected).
Fields of papers citing papers by Kelly E. Graff
This network shows the impact of papers produced by Kelly E. Graff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly E. Graff. The network helps show where Kelly E. Graff may publish in the future.
Co-authors
The 25 scholars most cited alongside Kelly E. Graff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 187 | |
| 2 | 2020 | 64 | |
| 3 | 2021 | 27 | |
| 4 | 2021 | 19 | |
| 5 | 2023 | 10 | |
| 6 | 2021 | 4 | |
| 7 | 2024 | 1 | |
| 8 | 2025 | 1 | |
| 9 | 2025 | 1 | |
| 10 | 2025 | 0 |
About Kelly E. Graff
Kelly E. Graff is a scholar working on Infectious Diseases, Clinical Biochemistry, Epidemiology, Applied Microbiology and Biotechnology and Critical Care and Intensive Care Medicine, having authored 10 papers that have together received 314 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (3 papers), Bacterial Identification and Susceptibility Testing (3 papers), Genomics and Phylogenetic Studies (1 paper), Infective Endocarditis Diagnosis and Management (1 paper), Respiratory viral infections research (1 paper), Bacteriophages and microbial interactions (1 paper), SARS-CoV-2 and COVID-19 Research (1 paper) and Ultrasound in Clinical Applications (1 paper). The work is most often cited by research in Infectious Diseases (143 citations), Obstetrics and Gynecology (31 citations), Clinical Biochemistry (22 citations), Neurology (32 citations) and Applied Microbiology and Biotechnology (4 citations). Kelly E. Graff has collaborated with scholars based in United States and Guatemala. Frequent co-authors include Lisa Abuogi, Christiana Smith, Lori J. Silveira, Elizabeth J. McFarland, Samuel R. Dominguez, Lauren M. Carpenter, Sarah A. Jung, Samuel R. Dominguez, Kevin Messacar and Claire Palmer. Their work appears in journals such as The Pediatric Infectious Disease Journal, Journal of the Pediatric Infectious Diseases Society, Journal of Clinical Microbiology, Microbiology Spectrum and BMC Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.